by Brigham and Women’s Hospital Central Illustration. Credit: Journal of the American College of Cardiology (2024). DOI: 10.1016/j.jacc.2023.10.038Direct oral anticoagulants (DOACs) are a common treatment for patients with a wide variety of cardiovascular conditions. DOACs are the preferred treatment over vitamin K antagonists (VKAs) for many patients with atrial fibrillation or venous thromboembolism since the latter...
by Hebrew SeniorLife Hinda and Arthur Marcus Institute for Aging Research Association of standard‐ vs reduced‐dose direct oral anticoagulants on outcomes. Detailed event rates, individuals at risk, and follow‐up times are presented in Table S6. IPTW indicates inverse probability treatment‐ and inverse probability censor‐weighted. Credit: Journal of the American Heart Association (2023). DOI: 10.1161/JAHA.122.029865 A...
by National Cerebral and Cardiovascular Center Credit: CC0 Public Domain Researchers at the National Cerebral and Cardiovascular Center (NCVC) in Japan propose the new optimal timings for starting direct oral anticoagulants (DOACs) in patients with nonvalvular atrial fibrillation (NVAF) after acute ischemic stroke, based on their results from combined registry dataset. They proposed the “1-2-3-4-day”...
